068270.KS Celltrion Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
07:30
May 08
May 08
Celltrion undervalued after strong earnings
Celltrion reported strong earnings, is expanding CDMO capacity (potential Eli Lilly deal), and has seen foreign buying. The stock price is not burdensome at current levels, and the biotech sector is showing signs of recovery.
MED
01:00
May 08
May 08
Good earnings, undervalued biotech
Celltrion posted stronger-than-expected earnings and has a catalyst in CDMO expansion in the U.S. (Eli Lilly contract). Foreign and institutional buying is emerging, and the stock offers a cheap valuation relative to its biotech peers.
MED
About 068270.KS Analyst Coverage
Buzzberg tracks 068270.KS (Celltrion Inc.) across 1 sources. 2 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 2 total trade ideas tracked.